EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunogenicity Analysis of PCV3 Recombinant Capsid Protein Virus-like Particles and Their Application in Antibodies Detection

Xuyang Cao, Min Huang, Ying Wang, Yanzhi Chen, Hanwen Yang, Fusheng Quan

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241210377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Xuyang Cao und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Northwest A&F University, Yangling 712100, China. Hauptthemen laut MEDLINE: Swine Diseases, Circovirus, Viral Vaccines. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: North West Agriculture and Forestry University, key program from Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Porcine circovirus type 3 is a newly emerging pathogen of porcine circovirus associated disease (PCVAD). Currently, there is no commercially available vaccine, resulting in huge economic losses to the pig industry. Porcine circovirus type 3 capsid protein (Cap) can self-assemble into virus-like particles (VLPs). Therefore, the expression of the recombinant Cap protein is of great significance for the prevention, diagnosis and control of porcine circovirus type 3 associated diseases. In this study, the recombinant Cap protein was successfully expressed in Escherichia coli by deleting the nuclear localization sequence (NLS). The VLPs were observed by transmission electron microscopy. To evaluate the immunogenicity of the recombinant Cap protein, mice were immunized. As a result, the recombinant Cap protein can induce higher levels of humoral and cellular immune responses. A VLP-based ELISA method was developed for the detection of antibodies. The established ELISA method has good sensitivity, specificity, repeatability and clinical applicability. These results demonstrate the successful expression of the PCV3 recombinant Cap protein and the preparation of recombinant Cap protein VLPs, which can be used for the preparation of subunit vaccines. Meanwhile, the established I-ELISA method lays a foundation for the development of the commercial PCV3 serological antibody detection kit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Swine DiseasesCircovirusViral VaccinesSwineAnimalsMiceCapsid ProteinsAntibodies, ViralRecombinant ProteinsEnzyme-Linked Immunosorbent Assay

Stichwörter der Autor:innen

capsid protein (Cap)enzyme-linked immunosorbent assay (ELISA)porcine circovirus type 3 (PCV3)virus-like particles (VLPs)

Substanzen

Capsid ProteinsAntibodies, ViralRecombinant ProteinsViral Vaccines

Autor:innen und Institutionen

  • College of Veterinary Medicine, Northwest A&F University, Yangling 712100, China.
  • Key Laboratory of Animal Biotechnology, Ministry of Agriculture, Yangling 712100, China.

Förderung

  • North West Agriculture and Forestry University
  • key program from Shaanxi Province

Zitieren

APA

Cao, X., Huang, M., Wang, Y., Chen, Y., Yang, H., & Quan, F. (2023). Immunogenicity Analysis of PCV3 Recombinant Capsid Protein Virus-like Particles and Their Application in Antibodies Detection. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241210377

Vancouver

Cao X, Huang M, Wang Y, Chen Y, Yang H, Quan F. Immunogenicity Analysis of PCV3 Recombinant Capsid Protein Virus-like Particles and Their Application in Antibodies Detection. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241210377

BibTeX
@article{Cao2023,
  author = {Cao, Xuyang and Huang, Min and Wang, Ying and Chen, Yanzhi and Yang, Hanwen and Quan, Fusheng},
  title = {Immunogenicity Analysis of PCV3 Recombinant Capsid Protein Virus-like Particles and Their Application in Antibodies Detection},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241210377}
}
Kostenlos starten →